Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

2 months Gilead increases 2024 outlook, expects new drug filing by end of year Yahoo Finance

Gilead increases 2024 outlook, expects new drug filing by end of year.

Gilead (GILD)

  X     

15 hours Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock Yahoo Finance

   X     

6 days Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

   X     

6 days Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks

   X     

1 week GILD’s Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer Zacks

   X     

1 week Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

   X     

1 week Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure Seeking Alpha

   X     

1 week GILD Obtains Positive CHMP Opinion for Liver Disease Drug Zacks

   X     

1 week Gilead (GILD) Upgraded to Buy: Here’s Why Zacks

   X     

2 weeks Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know Zacks

   X     

2 weeks Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Investing.com

   X     

2 weeks Is Gilead Sciences (GILD) Stock Undervalued Right Now? Zacks

   X     

2 weeks Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 weeks Final Trade: LMAT, GOOGL, IBM, GILD YouTube

   X     

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

3 weeks Gilead Sciences Is Turning Itself Around. Why Its Stock Can Keep Rallying. Yahoo Finance

   X     

3 weeks Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

   X     

3 weeks Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC Zacks

   X     

3 weeks Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha

   X     

3 weeks Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic? Zacks

   X     

4 weeks Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell? Zacks

   X     

4 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks

   X     

4 weeks Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks

   X     

1 month Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

   X     

1 month Market Digest: ADTN, EQR, GILD, NFG, PRU, MSCI Yahoo Finance

   X     

1 month Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet Zacks

   X     

1 month GILD or VRTX: Which Is the Better Value Stock Right Now? Zacks

   X     

2 months Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook Zacks

   X     

2 months Why Gilead’s Solid Q3 Earnings Could Point To A Dividend Surprise Next Year Seeking Alpha

   X     

2 months Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And Raise Investor's Business Daily

   X     

2 months Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance MarketWatch

   X     

2 months Gilead Science to Report Q3 Earnings: What’s in the Cards? Zacks

   X     

2 months Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks

   X     

2 months Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement System MarketBeat

   X     

2 months Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to Decline Zacks

   X     

2 months Gilead Sciences (GILD) Stock Sinks As Market Gains: Here’s Why Zacks

   X     

2 months Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of Canada MarketBeat

   X     

2 months Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by Brokerages MarketBeat

   X     

2 months Why Gilead Sciences (GILD) Dipped More Than Broader Market Today Zacks

   X     

2 months Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High – Still a Buy? MarketBeat

   X     

2 months Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Leerink Partnrs MarketBeat

   X     

2 months Gilead, MRK Report Data From Investigational Combination Study for HIV Zacks

   X     

2 months Calls of the Day: Gilead, Berkshire Hathaway and SLB YouTube

   X     

2 months Crew Capital Management Ltd. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat

   X     

2 months Gilead Sciences (NASDAQ:GILD) Upgraded by Leerink Partners to Outperform MarketBeat

   X     

2 months Stratos Investment Management LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat

   X     
More news +

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.

Home | Contact
  • X

© 2024 The Stock Market News